Le Lézard
Classified in: Health, Science and technology
Subjects: Product/Service, Podcast

Clinical Trials Tech Leader to Launch New Podcast Series Focused on Innovation and Trends in the Biotech, Healthtech, and Data Sectors


ClinCapture, the industry leader in decentralized clinical trial technology, today announced during the annual Outsourcing in Clinical Trials industry conference a new video podcast series to be sponsored by ClinCapture and hosted by CEO Scott Weidley. TRIALZ with Scott Weidley will provide viewers and listeners with informative and thought-provoking discussions that will occur at the intersection of emerging technology and healthcare. Episodes will focus on the key issues that are affecting today's health, pharma, and data industries including telemedicine, 5G, artificial intelligence, robotics, vaccine development, data security, and compliance.

For industry professionals, tech enthusiasts, and science-minded general audiences, deducing news and knowledge can be a tedious process, with the arduous task of attempting to identify developments and breakthroughs that traverse the worlds of tech, science, and healthcare. TRIALZ with Scott Weidley will serve as a one-stop shop to topics and trends in each respective sector, as well as new developments that are on the horizon.

Scott Weidley, CEO, ClinCapture and host of TRIALZ, said, "I hope TRIALZ will allow the flow of ideas, opinions, and outlooks from our unique guests and open them up to a broader audience who can contribute to the conversation in new and powerful ways."

TRIALZ with Scott Weidley is set to debut in January 2022 on www.clincapture.com.

Virtual Data Capture® is a registered trademark of ClinCapture, Inc.

About ClinCapture

ClinCapture is revolutionizing the clinical trial industry with Virtual Data Capture® and is the only provider of VDC®, a leading-edge suite of products designed to expedite remote and decentralized clinical trials. ClinCapture's eClinical products enable sponsors and CROs to rapidly build and deploy studies, lower clinical trial costs, and streamline data capture processes. ClinCapture's technologies help advance the evaluation and development of drugs, biologics, and devices that demonstrate promise for the diagnosis and/ or treatment of a wide range of diseases or medical conditions. For more information, please visitclincapture.com and follow ClinCapture on LinkedIn.


These press releases may also interest you

at 17:55
Life360 announces S-3 Filing
San Francisco area-based Life360, Inc. ("Life360" or the "Company") today announced that it has publicly filed an automatically effective registration statement on Form S-3 (Registration No. 333-279271) (including a base prospectus) with the U.S....

at 17:53
Charter Prices $3.0 Billion Senior Secured Notes
Charter Communications, Inc. (along with its subsidiaries, "Charter") today announced that its subsidiaries, Charter Communications Operating, LLC ("CCO") and Charter Communications Operating Capital Corp. ("CCO Capital," and together with CCO, the...

at 17:50
Save the Date: SGH Analyst Day on July 16, 2024
SMART Global Holdings, Inc. ("SGH" or the "Company") today announced that it will host an Analyst Day in New York City on Tuesday, July 16, 2024, at 10 a.m. Eastern Time. Live and on-demand webcasts of the event will be available on the SGH Investor...

at 17:46
FirmScribe Introduces FREE WhatsApp Capture For iMessage Capture Customers
FirmScribe, the leading provider of iMessage archiving and capturing solutions, today announced the launch of free WhatsApp capture for iMessage capture customers. This feature allows FirmScribe's iMessage capture customers to also effortlessly...

at 17:45
GreenPower Announces Closing of US$2.3 Million Underwritten Public Offering
GreenPower Motor Company Inc. ("GreenPower" or the "Company"), a leading manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and...

at 17:37
5N Plus Announces Election of Directors
5N Plus Inc.  ("5N+" or the "Company"), a leading global producer  of specialty semiconductors and performance materials, announced that the nominees listed in its Management Information Circular dated April 1, 2024 were elected as directors of 5N...

More news about Science and technology...


News published on and distributed by: